Abstract
The peptide hormone relaxin (RLX), in addition to its effects on reproduction, has been reported to influence gastrointestinal motility. Interestingly, the digestive tract has been shown to express RLX receptors and the hormone appears to exert site-specific effects acting at the neural or at the smooth muscle level, mainly by a nitric oxide (NO)-mediated mechanism. NO, released by the enteric nerves and/or smooth muscle cells, is one of the main mediators of gastrointestinal relaxation. In fact, in murine in vitro preparations, RLX depresses organ motility acting at the neural level in the stomach and at the muscular level in the small intestine; conversely, in the colon, this hormone paradoxically increases contractility operating at both neural and muscle levels. These effects are ascribable to the ability of RLX to selectively regulate the expression of the different nitric oxide synthase (NOS) isoforms in the different gastrointestinal tracts. Furthermore, recent electrophysiological experiments have shown that RLX can directly affect the biophysical properties of ileal and colonic smooth muscle cells.
This mini-review is intended to offer an update on the site-related actions of RLX on gastrointestinal tract motility in relation with its site-specific effects on NOS isoforms expression. Based on these properties, RLX might be considered a potential therapeutic approach to gastrointestinal motor dysfunctions related to an altered NO production.
Keywords: Relaxin, nitric oxide, gastrointestinal tract, smooth muscle, nitric oxide synthase, gut motility.
Current Protein & Peptide Science
Title:Site-related Effects of Relaxin in the Gastrointestinal Tract Through Nitric Oxide Signalling: An Updated Report
Volume: 18 Issue: 12
Author(s): Rachele Garella, Roberta Squecco and Maria Caterina Baccari*
Affiliation:
- Department of Experimental and Clinical Medicine, Section of Physiology, University of Florence, Viale G.B. Morgagni 63, 50134 Florence,Italy
Keywords: Relaxin, nitric oxide, gastrointestinal tract, smooth muscle, nitric oxide synthase, gut motility.
Abstract: The peptide hormone relaxin (RLX), in addition to its effects on reproduction, has been reported to influence gastrointestinal motility. Interestingly, the digestive tract has been shown to express RLX receptors and the hormone appears to exert site-specific effects acting at the neural or at the smooth muscle level, mainly by a nitric oxide (NO)-mediated mechanism. NO, released by the enteric nerves and/or smooth muscle cells, is one of the main mediators of gastrointestinal relaxation. In fact, in murine in vitro preparations, RLX depresses organ motility acting at the neural level in the stomach and at the muscular level in the small intestine; conversely, in the colon, this hormone paradoxically increases contractility operating at both neural and muscle levels. These effects are ascribable to the ability of RLX to selectively regulate the expression of the different nitric oxide synthase (NOS) isoforms in the different gastrointestinal tracts. Furthermore, recent electrophysiological experiments have shown that RLX can directly affect the biophysical properties of ileal and colonic smooth muscle cells.
This mini-review is intended to offer an update on the site-related actions of RLX on gastrointestinal tract motility in relation with its site-specific effects on NOS isoforms expression. Based on these properties, RLX might be considered a potential therapeutic approach to gastrointestinal motor dysfunctions related to an altered NO production.
Export Options
About this article
Cite this article as:
Garella Rachele , Squecco Roberta and Baccari Caterina Maria*, Site-related Effects of Relaxin in the Gastrointestinal Tract Through Nitric Oxide Signalling: An Updated Report, Current Protein & Peptide Science 2017; 18 (12) . https://dx.doi.org/10.2174/1389203718666170612104719
DOI https://dx.doi.org/10.2174/1389203718666170612104719 |
Print ISSN 1389-2037 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5550 |
Call for Papers in Thematic Issues
Advancements in Proteomic and Peptidomic Approaches in Cancer Immunotherapy: Unveiling the Immune Microenvironment
The scope of this thematic issue centers on the integration of proteomic and peptidomic technologies into the field of cancer immunotherapy, with a particular emphasis on exploring the tumor immune microenvironment. This issue aims to gather contributions that illustrate the application of these advanced methodologies in unveiling the complex interplay ...read more
Nutrition and Metabolism in Musculoskeletal Diseases
The musculoskeletal system consists mainly of cartilage, bone, muscles, tendons, connective tissue and ligaments. Balanced metabolism is of vital importance for the homeostasis of the musculoskeletal system. A series of musculoskeletal diseases (for example, sarcopenia, osteoporosis) are resulted from the dysregulated metabolism of the musculoskeletal system. Furthermore, metabolic diseases (such ...read more
Protein Folding, Aggregation and Liquid-Liquid Phase Separation
Protein folding, misfolding and aggregation remain one of the main problems of interdisciplinary science not only because many questions are still open, but also because they are important from the point of view of practical application. Protein aggregation and formation of fibrillar structures, for example, is a hallmark of a ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Immune Mechanisms and Novel Pharmacological Therapies of Acute Kidney Injury
Current Drug Targets Exercise Preconditioning Reduces Brain Damage and Inhibits TNF-α Receptor Expression after Hypoxia/Reoxygenation: An In Vivo and In Vitro Study
Current Neurovascular Research Uridine Function in the Central Nervous System
Current Topics in Medicinal Chemistry Up-Regulation of TLR-4 in the Brain After Ischemic Kidney-Induced Encephalopathy in the Rat
CNS & Neurological Disorders - Drug Targets The No-Reflow Phenomenon in the Coronary Circulation
Cardiovascular & Hematological Agents in Medicinal Chemistry Advances in Design and Development of Inhibitors of Nitric Oxide Synthases
Current Enzyme Inhibition The Emerging Role of microRNA in Stroke
Current Topics in Medicinal Chemistry Pleiotropic Effects of PPARγ Agonist on Hemostatic Activation in Type 2 Diabetes Mellitus
Current Vascular Pharmacology Mitochondrial Targeting for Development of Novel Drug Strategies in Brain Injury
Central Nervous System Agents in Medicinal Chemistry Adverse Effects of Statins - Mechanisms and Consequences
Current Drug Safety Current Drug Nano-targeting Strategies for Improvement in the Diagnosis and Treatment of Prevalent Pathologies such as Cardiovascular and Renal Diseases
Current Drug Targets Measurement of Cerebral Blood Flow with Near Infrared Spectroscopy and Indocyanine Green Dye Dilution
Current Medical Imaging Structure-Activity Relationships of Multifunctional Host Defence Peptides
Mini-Reviews in Medicinal Chemistry From Concept to Reality: The Long Road to c-Met and RON Receptor Tyrosine Kinase Inhibitors for the Treatment of Cancer
Anti-Cancer Agents in Medicinal Chemistry Cytosolic Phospholipase A2 Inhibitors as Therapeutic Agents for Neural Cell Injury
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Isolated-Perfused Heart: The Preparation that has been used as a Research Tool for More than a Century
Drug Design Reviews - Online (Discontinued) Potential Role of Polyphenols in the Prevention of Cardiovascular Diseases: Molecular Bases
Current Medicinal Chemistry Recent Patents, Regulatory Issues, and Toxicity of Nanoparticles in Neuronal Disorders
Current Drug Metabolism Clinical Aspects and Therapeutic Perspectives of Relaxin
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents High Mobility Group Box 1 Protein as a Potential Drug Target for Infection- and Injury-Elicited Inflammation
Inflammation & Allergy - Drug Targets (Discontinued)